REVERBERI, CHIARA
REVERBERI, CHIARA
30 Gy single dose stereotactic body radiation therapy (SBRT). Report on outcome in a large series of patients with lung oligometastatic disease
2018 Osti, M. F.; Agolli, L.; Valeriani, M.; Reverberi, C.; Bracci, S.; Marinelli, L.; De Sanctis, V.; Cortesi, E.; Martelli, M.; De Dominicis, C.; Minniti, G.; Nicosia, L.
A multi-institutional analysis of fractionated versus single-fraction stereotactic body radiotherapy (SBRT) in the treatment of primary lung tumors. a comparison between two antipodal fractionations
2021 Alongi, F.; Nicosia, L.; Figlia, V.; De Sanctis, V.; Mazzola, R.; Giaj-Levra, N.; Reverberi, C.; Valeriani, M.; Osti, M. F.
Inoperable early-stage primary and early recurrent non-small cell lung cancer: outcomes of a mono-institutional experience using a moderate hypofractionated schedule
2019 Valeriani, M.; Marinelli, L.; Reverberi, C.; De Sanctis, V.; Mollo, D.; Nicosia, L.; Osti, M. F.
Local and metastatic curative radiotherapy in patients with de novo oligometastatic prostate cancer
2020 Reverberi, C.; Massaro, M.; Osti, M. F.; Anzellini, D.; Marinelli, L.; Montalto, A.; De Sanctis, V.; Valeriani, M.
Locally advanced inoperable primary or recurrent non-small cell lung cancer treated with 4-week hypofractionated radiation therapy (3 Gy/fraction)
2019 Valeriani, M.; Marinelli, L.; Nicosia, L.; Reverberi, C.; De Sanctis, V.; Mollo, D.; Osti, M. F.
Long term results of single high dose Stereotactic Body Radiotherapy in the treatment of primary lung tumors
2019 Nicosia, L.; Reverberi, C.; Agolli, L.; Marinelli, L.; De Sanctis, V.; Valeriani, M.; Osti, M. F.
Moderate hypofractionation in patients with low-risk prostate cancer: long-term outcomes
2018 Valeriani, Maurizio; Bonfili, Pierluigi; Reverberi, Chiara; Marinelli, Luca; Ferella, Letizia; Minniti, Giuseppe; DE Sanctis, Vitaliana; Osti, Mattia Falchetto; Bonome, Paolo; Tronnolone, Lidia; Varrassi, Emilia; Gravina, Giovanni Luca; Franzese, Pietro; Tombolini, Vincenzo; DI Staso, Mario
Mono-and Bi-weekly hypofractionated radiation therapy for the treatment of epithelial skin cancer in very elderly patients
2017 Valeriani, Maurizio; Nicosia, Luca; Agolli, Linda; Reverberi, Chiara; Galvagno, Emanuela; De Sanctis, Vitaliana; Minniti, Giuseppe; Carlesimo, Marta; Osti, Mattia F.
Multislice computed tomography coronary angiography: Clinical applications
2007 Cademartiri, F.; Aldrovandi, A.; Palumbo, A.; Maffei, E.; Fusaro, M.; Tresoldi, S.; Messalli, G.; Rossi, A.; Rengo, M.; Pugliese, F.; Salamousas, B. V.; Reverberi, C.; Meijboom, W. B.; Mollet, N. R.; Ardissino, D.; De Feyter, P. J.
Oligoprogression during Abiraterone therapy treated with radiotherapy in mCRPC patients.
2018 Marinelli, L; Reverberi, C; Nicosia, L; Macrini, S; Giacinti, S; Poti, G; Arrivi, G; Osti, M; De Sanctis, V; Proietti, C; Aschelter, A; Marchetti, P; Valeriani, M
Orbital radiotherapy plus concomitant steroids in moderate-to-severe graves’ ophthalmopathy. Good results after long-term follow-up
2019 Nicosia, L.; Reverberi, C.; Agolli, L.; Marinelli, L.; De Sanctis, V.; Minniti, G.; Valeriani, M.; Osti, M. F.
Post-mastectomy immediate breast reconstruction and adjuvant radiotherapy. long term results of a mono institutional experience
2020 Reverberi, C.; Marinelli, L.; Campanella, B.; Scalabrino, G.; Nicosia, L.; Anzellini, D.; De Sanctis, V.; Valeriani, M.; Osti, M. F.
Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment. A mono-institutional experience
2019 Valeriani, M.; Marinelli, L.; Macrini, S.; Reverberi, C.; Aschelter, A. M.; De Sanctis, V.; Marchetti, P.; Tronnolone, L.; Osti, M. F.
Single nucleotide polymorphism of gstp1 and pathological complete response in locally advanced rectal cancer patients treated with neoadjuvant concomitant radiochemotherapy
2018 Nicosia, L.; Gentile, G.; Reverberi, C.; Minniti, G.; Valeriani, M.; de Sanctis, V.; Marinelli, L.; Cipolla, F.; de Luca, O.; Simmaco, M.; Osti, M. F.
Stereotactic and hypofractionated radiotherapy associated with immune checkpoint inhibitor drugs. Analysis of local control, toxicity, and outcome in a single research centre case study
2021 Anzellini, D.; de Sanctis, V.; Valeriani, M.; Reverberi, C.; Marinelli, L.; Massaro, M.; Vullo, G.; Facondo, G.; Sigillo, R. C.; Tosi, E.; Osti, M. F.
Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: Evaluation of brain control and toxicity
2019 Minniti, G.; Anzellini, D.; Reverberi, C.; Cappellini, G. C. A.; Marchetti, L.; Bianciardi, F.; Bozzao, A.; Osti, M.; Gentile, P. C.; Esposito, V.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 30 Gy single dose stereotactic body radiation therapy (SBRT). Report on outcome in a large series of patients with lung oligometastatic disease | 2018 | Osti, M. F.; Agolli, L.; Valeriani, M.; Reverberi, C.; Bracci, S.; Marinelli, L.; De Sanctis, V.; Cortesi, E.; Martelli, M.; De Dominicis, C.; Minniti, G.; Nicosia, L. | |
| A multi-institutional analysis of fractionated versus single-fraction stereotactic body radiotherapy (SBRT) in the treatment of primary lung tumors. a comparison between two antipodal fractionations | 2021 | Alongi, F.; Nicosia, L.; Figlia, V.; De Sanctis, V.; Mazzola, R.; Giaj-Levra, N.; Reverberi, C.; Valeriani, M.; Osti, M. F. | |
| Inoperable early-stage primary and early recurrent non-small cell lung cancer: outcomes of a mono-institutional experience using a moderate hypofractionated schedule | 2019 | Valeriani, M.; Marinelli, L.; Reverberi, C.; De Sanctis, V.; Mollo, D.; Nicosia, L.; Osti, M. F. | |
| Local and metastatic curative radiotherapy in patients with de novo oligometastatic prostate cancer | 2020 | Reverberi, C.; Massaro, M.; Osti, M. F.; Anzellini, D.; Marinelli, L.; Montalto, A.; De Sanctis, V.; Valeriani, M. | |
| Locally advanced inoperable primary or recurrent non-small cell lung cancer treated with 4-week hypofractionated radiation therapy (3 Gy/fraction) | 2019 | Valeriani, M.; Marinelli, L.; Nicosia, L.; Reverberi, C.; De Sanctis, V.; Mollo, D.; Osti, M. F. | |
| Long term results of single high dose Stereotactic Body Radiotherapy in the treatment of primary lung tumors | 2019 | Nicosia, L.; Reverberi, C.; Agolli, L.; Marinelli, L.; De Sanctis, V.; Valeriani, M.; Osti, M. F. | |
| Moderate hypofractionation in patients with low-risk prostate cancer: long-term outcomes | 2018 | Valeriani, Maurizio; Bonfili, Pierluigi; Reverberi, Chiara; Marinelli, Luca; Ferella, Letizia; Minniti, Giuseppe; DE Sanctis, Vitaliana; Osti, Mattia Falchetto; Bonome, Paolo; Tronnolone, Lidia; Varrassi, Emilia; Gravina, Giovanni Luca; Franzese, Pietro; Tombolini, Vincenzo; DI Staso, Mario | |
| Mono-and Bi-weekly hypofractionated radiation therapy for the treatment of epithelial skin cancer in very elderly patients | 2017 | Valeriani, Maurizio; Nicosia, Luca; Agolli, Linda; Reverberi, Chiara; Galvagno, Emanuela; De Sanctis, Vitaliana; Minniti, Giuseppe; Carlesimo, Marta; Osti, Mattia F. | |
| Multislice computed tomography coronary angiography: Clinical applications | 2007 | Cademartiri, F.; Aldrovandi, A.; Palumbo, A.; Maffei, E.; Fusaro, M.; Tresoldi, S.; Messalli, G.; Rossi, A.; Rengo, M.; Pugliese, F.; Salamousas, B. V.; Reverberi, C.; Meijboom, W. B.; Mollet, N. R.; Ardissino, D.; De Feyter, P. J. | |
| Oligoprogression during Abiraterone therapy treated with radiotherapy in mCRPC patients. | 2018 | Marinelli, L; Reverberi, C; Nicosia, L; Macrini, S; Giacinti, S; Poti, G; Arrivi, G; Osti, M; De Sanctis, V; Proietti, C; Aschelter, A; Marchetti, P; Valeriani, M | |
| Orbital radiotherapy plus concomitant steroids in moderate-to-severe graves’ ophthalmopathy. Good results after long-term follow-up | 2019 | Nicosia, L.; Reverberi, C.; Agolli, L.; Marinelli, L.; De Sanctis, V.; Minniti, G.; Valeriani, M.; Osti, M. F. | |
| Post-mastectomy immediate breast reconstruction and adjuvant radiotherapy. long term results of a mono institutional experience | 2020 | Reverberi, C.; Marinelli, L.; Campanella, B.; Scalabrino, G.; Nicosia, L.; Anzellini, D.; De Sanctis, V.; Valeriani, M.; Osti, M. F. | |
| Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment. A mono-institutional experience | 2019 | Valeriani, M.; Marinelli, L.; Macrini, S.; Reverberi, C.; Aschelter, A. M.; De Sanctis, V.; Marchetti, P.; Tronnolone, L.; Osti, M. F. | |
| Single nucleotide polymorphism of gstp1 and pathological complete response in locally advanced rectal cancer patients treated with neoadjuvant concomitant radiochemotherapy | 2018 | Nicosia, L.; Gentile, G.; Reverberi, C.; Minniti, G.; Valeriani, M.; de Sanctis, V.; Marinelli, L.; Cipolla, F.; de Luca, O.; Simmaco, M.; Osti, M. F. | |
| Stereotactic and hypofractionated radiotherapy associated with immune checkpoint inhibitor drugs. Analysis of local control, toxicity, and outcome in a single research centre case study | 2021 | Anzellini, D.; de Sanctis, V.; Valeriani, M.; Reverberi, C.; Marinelli, L.; Massaro, M.; Vullo, G.; Facondo, G.; Sigillo, R. C.; Tosi, E.; Osti, M. F. | |
| Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: Evaluation of brain control and toxicity | 2019 | Minniti, G.; Anzellini, D.; Reverberi, C.; Cappellini, G. C. A.; Marchetti, L.; Bianciardi, F.; Bozzao, A.; Osti, M.; Gentile, P. C.; Esposito, V. |